A unified system of European patents has been a goal of those working towards European integration since before the establishment…
In our recent blog on trends in international reference pricing (IRP), we mentioned that a public consultation was underway in Brazil on…
The coronavirus disease 2019 (COVID-19) pandemic and governments responses are still impacting the pharmaceutical market globally, according to our latest…
The ongoing controversy over Biogen's Aduhelm treatment shows that pricing scrutiny has risen to a new level. The backlash after…
The highly transmissible COVID-19 Delta variant highlights the importance of vaccines to both health and economic recovery, with widespread vaccination…
Generic drug manufacturers have warned that up to 90% of drugs currently supplied to Northern Ireland may be threatened with withdrawal as…
For international pharmaceutical companies, Lebanon has long been a small but important export market. Until recently, at around 50% of…
In early May, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) approved a targeted anticancer drug, AstraZeneca's Tagrisso (osimertinib),…
Pharmaceutical prices in central and eastern European (CEE) countries tend to be low and drop over time - a double…
In a highly significant move, the US government has announced its backing for a waiver on intellectual property (IP) protection…
